| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 12 Feb 24 | IMGN Immunogen | RSU Common Stock | Sale back to company | Acquire D | No | No | 0 | 19,519 | 0.00 | 0 |
| 12 Feb 24 | IMGN Immunogen | RSU Common Stock | Sale back to company | Acquire D | No | No | 0 | 51,625 | 0.00 | 0 |
| 12 Feb 24 | IMGN Immunogen | Stock Option Common Stock | Sale back to company | Acquire D | No | No | 15.71 | 295,975 | 4.65 mm | 0 |
| 1 Feb 24 | IMGN Immunogen | RSU Common Stock | Grant | Acquire A | No | No | 0 | 19,519 | 0.00 | 19,519 |
| 18 Sep 23 | IMGN Immunogen | RSU Common Stock | Grant | Acquire A | No | No | 0 | 51,625 | 0.00 | 51,625 |
| 18 Sep 23 | IMGN Immunogen | Stock Option Common Stock | Grant | Acquire A | No | No | 15.71 | 295,975 | 4.65 mm | 295,975 |
| 30 Aug 23 | CCCC C4 Therapeutics | Common Stock | Payment of exercise | Dispose F | No | No | 2.93 | 661 | 1.94 k | 32,686 |
| 30 Aug 23 | CCCC C4 Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 0 | 2,250 | 0.00 | 33,347 |
| 30 Aug 23 | CCCC C4 Therapeutics | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 2,250 | 0.00 | 16,500 |
